The burden of left ventricular assist device (LVAD) infections on costs, lengths of stay, antimicrobial consumption and resistance: a prospective case control approach
Abstract Background Congestive heart failure has reached pandemic levels, and left-ventricular assist devices (LVAD) are increasingly used to treat refractory heart failure. Infection is a leading complication of LVADs. Despite numerous reports (most being retrospective), several knowledge gaps pert...
Saved in:
| Main Authors: | Matthew Ficinski, Jennifer West, Shannon Glassman, Katrina Wojciechowski, Jennifer Gutowski, Maryrose Laguio-Vila, Scott Feitell, Emil Lesho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Antimicrobial Resistance and Infection Control |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13756-024-01503-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rezafungin for suppressive therapy of Candida auris in a patient with a left ventricular assist device (LVAD)
by: Matthew A. Stack, et al.
Published: (2025-01-01) -
Percutaneous Intervention of LVAD Outflow Graft Obstruction and Thrombosis
by: Andrew Takla, et al.
Published: (2024-04-01) -
Repair of Dissecting Aortic Aneurysm in Post-LVAD Patient
by: Sanjay Chaubey, et al.
Published: (2024-06-01) -
ERAS including minimal Narcotic Pain Management Is Successful After Heart Transplant and LVAD Implantation: A Single Center Review
by: Joseph Elder, PharmD BCPS, et al.
Published: (2025-08-01) -
Trends in LVAD Placements and Outcomes: A Nationwide Analysis Using the National Inpatient Sample and National Readmissions Database
by: Vivek Joseph Varughese, et al.
Published: (2025-05-01)